by Vlad Tropko | Jun 23, 2020 | Investment Opportunity, Startups
Image Credit: alexsl/Getty Images The COVID-19 pandemic has naturally made venture capitalists more cautious. Pitchbook analysts estimate that in the first quarter of 2020, the number of venture deals made in the 10 largest countries in Europe almost halved compared...
by Reuters | Jun 5, 2020 | Investment Opportunity, News, Venture Funding
GENEVA/ZURICH (Reuters) – The World Health Organization announced on Wednesday the creation of a foundation to tap new sources of funding that could help ease a potential cash shortage as it leads the global fight against the coronavirus pandemic. Announcing...
by Medgadget Editors | Feb 6, 2020 | BioPharma, Inspiration, Investment Opportunity, News
The development of electronic skin is certainly an important part of future prosthetic devices. To make a high quality artificial skin, one would have to make a very flexible system seeded with many sensors, all wired somehow to a central core where the data can be...
by Jan Wolfe | Dec 20, 2019 | News, Investment Opportunity, Venture Funding
FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an employee in Le Passage, near Agen, France March 29, 2018. REUTERS/Regis Duvignau (Reuters) – Bristol-Myers Squibb Co on Friday said it won a $752 million...
by Patrick Cooley | Dec 5, 2019 | News, Inspiration, Investment Opportunity, Startups, Venture Funding
Ohio’s cannabis dispensaries deal largely in cash because banks and credit card companies are leery of working with medical marijuana companies. An Arizona company is aiming to fill the gap for those who prefer cashless payments. It’s providing a service...
by John Miller | Nov 21, 2019 | News, Investment Opportunity
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann/File Photo ZURICH (Reuters) – Swiss drugmaker Roche is paying up to $1.4 billion to buy U.S. biotech company Promedior, whose...
